Pain News and Research

Latest Pain News and Research

MigreLief releases safe, proven effective supplement for children with migraines

MigreLief releases safe, proven effective supplement for children with migraines

Herbal pain medication gets fractured runner back running again

Herbal pain medication gets fractured runner back running again

Santen files IND for Clinical Data's ATL313 for primary open angle glaucoma and ocular hypertension

Santen files IND for Clinical Data's ATL313 for primary open angle glaucoma and ocular hypertension

FDA approves Gardasil for prevention of anal cancer

FDA approves Gardasil for prevention of anal cancer

Minorities with MS may face risk of developing depressive symptoms

Minorities with MS may face risk of developing depressive symptoms

FDA joins Abbott Diabetes Careto to recall 359 glucose test strips

FDA joins Abbott Diabetes Careto to recall 359 glucose test strips

Researchers receive $100,000 NFL grant to study tissue engineering for spinal injuries

Researchers receive $100,000 NFL grant to study tissue engineering for spinal injuries

Spinal Botox injection reduces pain

Spinal Botox injection reduces pain

Genmed obtains marketing authorization license for paracetamol in Europe

Genmed obtains marketing authorization license for paracetamol in Europe

Smoking can increase pain severity in cancer patients

Smoking can increase pain severity in cancer patients

Chronic fatigue syndrome not linked to virus

Chronic fatigue syndrome not linked to virus

Gym injury prevention advice for the New Year

Gym injury prevention advice for the New Year

Halt Medical presents results of Halt Fibroid Study at NIH Global Fibroid Congress

Halt Medical presents results of Halt Fibroid Study at NIH Global Fibroid Congress

Training more effective than anti-inflammatory drugs in treating tennis elbow

Training more effective than anti-inflammatory drugs in treating tennis elbow

Biomet Biologics completes enrollment in Recover Kit clinical trial for chronic tennis elbow

Biomet Biologics completes enrollment in Recover Kit clinical trial for chronic tennis elbow

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

Britain’s NHS falls short in providing services

Britain’s NHS falls short in providing services

Brilinta – AstraZeneca’s new blood thinner faces FDA hurdle

Brilinta – AstraZeneca’s new blood thinner faces FDA hurdle

Forest acquires all rights held by Gruenenthal for colistin

Forest acquires all rights held by Gruenenthal for colistin

OXIS International files patent application to strengthen Ergothioneine intellectual property portfolio

OXIS International files patent application to strengthen Ergothioneine intellectual property portfolio

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.